Hims & Hers’ USD 1.15bn Eucalyptus deal signals new era for Australia’s digital health
US telehealth giant Hims & Hers’ USD 1.15bn acquisition in February of Australian digital health company Eucalyptus is expected to significantly shake…
19,173$
-3,36%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims & Hers Health (HIMS) Expands Offerings with Novo Nordisk Medications
Key Takeaways: Hims & Hers Health (HIMS) expands its product offerings by selling Novo Nordisks GLP-1 drugs,…
-3.50% for Hims & Hers Health stock as daily low tests immediate support
Hims & Hers Health trades at $20.11 today, down 3.50%. Sellers dominate as price stays below key moving averages and…
Hims & Hers Health starts selling Novo Nordisks Wegovy, Ozempic
Hims & Hers now sells Novo Nordisk’s Wegovy and Ozempic for weight loss and type 2 diabetes. Read more here.…
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform
Hims & Hers Health Inc. (HIMS) on Thursday announced the availability of a wide range of Novo Nordisk’s (NVO) GLP-1…